Results 11 to 20 of about 461,852 (357)

Acknowledgment to the Reviewers of Hematology Reports in 2022

Hematology Reports, 2023
High-quality academic publishing is built on rigorous peer review [...]
Hematology Reports Editorial Office
doaj   +1 more source

Synthetic Data Generation by Artificial Intelligence to Accelerate Research and Precision Medicine in Hematology

JCO Clinical Cancer Informatics, 2023
PURPOSE Synthetic data are artificial data generated without including any real patient information by an algorithm trained to learn the characteristics of a real source data set and became widely used to accelerate research in life sciences. We aimed to
S. D'amico, Daniele Dall’Olio, C. Sala, Lorenzo Dall’Olio, Elisabetta Sauta, Matteo Zampini, G. Asti, L. Lanino, G. Maggioni, Alessia Campagna, M. Ubezio, Antonio Russo, M. Bicchieri, E. Riva, C. Tentori, E. Travaglino, Pierandrea Morandini, V. Savevski, A. Santoro, Iñigo Prada-Luengo, A. Krogh, V. Santini, S. Kordasti, U. Platzbecker, M. Díez-Campelo, P. Fenaux, T. Haferlach, G. Castellani, M. D. Della Porta   +28 more
semanticscholar   +1 more source

Large Language Models in Hematology Case Solving: A Comparative Study of ChatGPT-3.5, Google Bard, and Microsoft Bing

Cureus, 2023
Background Large language models (LLMs), such as ChatGPT-3.5, Google Bard, and Microsoft Bing, have shown promising capabilities in various natural language processing (NLP) tasks.
Amita Kumari, Anita Kumari, Amita Singh, S. Singh, Ayesha Juhi, Anup Kumar D Dhanvijay, M. Pinjar, Himel Mondal   +7 more
semanticscholar   +1 more source

American Society of Hematology 2020 guidelines for management of venous thromboembolism: treatment of deep vein thrombosis and pulmonary embolism.

Blood Advances, 2020
BACKGROUND Venous thromboembolism (VTE), which includes deep vein thrombosis (DVT) and pulmonary embolism (PE), occurs in ∼1 to 2 individuals per 1000 each year, corresponding to ∼300 000 to 600 000 events in the United States annually. OBJECTIVE These
T. Ortel, I. Neumann, W. Ageno, R. Beyth, N. Clark, A. Cuker, B. Hutten, M. Jaff, Veena Manja, S. Schulman, Caitlin Thurston, S. Vedantham, P. Verhamme, D. Witt, Ivan D. Florez, A. Izcovich, R. Nieuwlaat, S. Ross, Holger J. Schünemann, W. Wiercioch, Yuan Zhang, Yuqing Zhang   +21 more
semanticscholar   +1 more source

An overview and a roadmap for artificial intelligence in hematology and oncology

Journal of Cancer Research and Clinical Oncology, 2023
Artificial intelligence (AI) is influencing our society on many levels and has broad implications for the future practice of hematology and oncology. However, for many medical professionals and researchers, it often remains unclear what AI can and cannot
Wiebke Rösler, M. Altenbuchinger, B. Baessler, T. Beissbarth, G. Beutel, R. Bock, N. von Bubnoff, Jan-Niklas Eckardt, S. Foersch, C. Loeffler, J. Middeke, Martha Mueller, T. Oellerich, Benjamin Risse, A. Scherag, C. Schliemann, M. Scholz, R. Spang, C. Thielscher, I. Tsoukakis, Jakob Nikolas Kather   +20 more
semanticscholar   +1 more source

American Society of Hematology 2020 guidelines for sickle cell disease: transfusion support.

Blood Advances, 2020
BACKGROUND Red cell transfusions remain a mainstay of therapy for patients with sickle cell disease (SCD), but pose significant clinical challenges. Guidance for specific indications and administration of transfusion, as well as screening, prevention ...
S. Chou, Mouaz Alsawas, R. Fasano, Joshua J Field, J. Hendrickson, J. Howard, Michelle Kameka, J. Kwiatkowski, F. Pirenne, Patricia A. Shi, S. Stowell, S. Thein, C. Westhoff, Trisha E. Wong, E. Akl   +14 more
semanticscholar   +1 more source

Hematology Reference Intervals for Holstein Cows in Southern China: A Study of 786 Subjects

Veterinary Sciences, 2022
Hematology RIs help clinicians and researchers determine whether a hematology parameter is abnormal, which plays an important role in animal health surveillance.
Hongbo Chen, Bo Yu, Chenhui Liu, Lei Cheng, Jie Yu, Xiuzhong Hu, Min Xiang   +6 more
doaj   +1 more source

Next generations of CAR-T cells - new therapeutic opportunities in hematology?

Frontiers in Immunology, 2022
In recent years, the introduction of chimeric antigen receptor (CAR) T-cell therapies into clinics has been a breakthrough in treating relapsed or refractory malignancies in hematology and oncology.
Jaromir Tomasik, M. Jasiński, G. Basak
semanticscholar   +1 more source

American Society of Hematology 2019 guidelines for immune thrombocytopenia.

Blood Advances, 2019
BACKGROUND Despite an increase in the number of therapies available to treat patients with immune thrombocytopenia (ITP), there are minimal data from randomized trials to assist physicians with the management of patients. OBJECTIVE These evidence-based
C. Neunert, Deirdra R. Terrell, D. Arnold, G. Buchanan, D. Cines, N. Cooper, A. Cuker, J. Despotovic, J. George, R. Grace, T. Kühne, D. Kuter, W. Lim, K. McCrae, Barbara Pruitt, Hayley Shimanek, S. Vesely   +16 more
semanticscholar   +1 more source

The American Society of Pediatric Hematology Oncology workforce, productivity, and fellowship assessment: Current state of the workforce

Pediatric Blood & Cancer, 2023
The American Society of Pediatric Hematology Oncology conducted follow‐up workforce surveys in 2017 and 2021 as well as a Pediatric Hematology Oncology Fellowship Program Directors Survey in 2020 to provide an updated review of the current workforce.
C. Hastings, S. Borinstein, D. Bergsagel, J. Hagstrom, Ryan Hooker, Diane J Nugent, M. Hudspeth   +6 more
semanticscholar   +1 more source